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h i g h l i g h t s
 Seizure detection algorithm (SDA) validated on unseen, unedited EEG of 70 neonates.
 Results at SDA sensitivity settings of 0.5–0.3 acceptable for clinical use.
 Seizure detection rate of 52.6–75.0%, false detection rate 0.04–0.36 FD/h.
a b s t r a c t
Objective: The objective of this study was to validate the performance of a seizure detection algorithm
(SDA) developed by our group, on previously unseen, prolonged, unedited EEG recordings from 70 babies
from 2 centres.
Methods: EEGs of 70 babies (35 seizure, 35 non-seizure) were annotated for seizures by experts as the
gold standard. The SDA was tested on the EEGs at a range of sensitivity settings. Annotations from the
expert and SDA were compared using event and epoch based metrics. The effect of seizure duration on
SDA performance was also analysed.
Results: Between sensitivity settings of 0.5 and 0.3, the algorithm achieved seizure detection rates of
52.6–75.0%, with false detection (FD) rates of 0.04–0.36 FD/h for event based analysis, which was deemed
to be acceptable in a clinical environment. Time based comparison of expert and SDA annotations using
Cohen’s Kappa Index revealed a best performing SDA threshold of 0.4 (Kappa 0.630). The SDA showed
improved detection performance with longer seizures.
Conclusion: The SDA achieved promising performance and warrants further testing in a live clinical eval-
uation.
Signiﬁcance: The SDA has the potential to improve seizure detection and provide a robust tool for com-
paring treatment regimens.
 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The concept of ‘‘neuroprotective’’ intensive care has now
reached neonatal units worldwide, in part driven by the results
of randomized controlled trials showing that therapeutic
hypothermia is beneﬁcial for term babies with a recent
hypoxic-ischaemic injury (Glass et al., 2011). The practice of neuro-
protective care involves careful monitoring of carbon dioxide ten-
sion, blood pressure and other physiological variables and is ideally
accompanied by continuous cotside EEG monitoring. Without EEG
monitoring many seizures are missed. The inaccuracy of clinical
recognition of seizures was demonstrated by Murray et al.
(2008). In this study, comparing EEG evidence of seizures to the
seizure detection acumen of NICU staff based on clinical evidence
alone, of 526 EEG seizures, only 179 (34%) had any clinical accom-
paniment, overdiagnosis was common with only 48 of 177 (27%)
clinically suspected events accompanied by EEG seizures such that
only 48/526 (9%) of EEG seizures were correctly identiﬁed by clin-
ical observation. Amplitude-integrated EEG (aEEG) is widely used
in NICUs for seizure detection but has been shown to perform
poorly (Rennie et al., 2004). In this study seizure detection by four
non-experts using CFM traces at 3 paper speeds were compared
against simultaneous EEG in 19 babies. Sensitivities of only 38%
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at 6 cm/h, 54% at 15 cm/h and 55% at 30 cm/h were achieved and
agreement between observers was poor at all speeds (j values
from 0.01 to 0.39). Treating seizures to electrical quiescence has
yet to be proven of any long-term beneﬁt, but there is evidence
from animal models (Wirrell et al., 2001), and clinical studies
(Glass et al., 2009; Shah et al., 2014) which would support the prin-
ciple that seizures do inﬂict further brain injury. Attempts to ame-
liorate such damage must be accompanied by prompt and reliable
detection of seizures. In addition, good quality randomized con-
trolled trials of new antiepileptic drugs are impossible without
robust and reproducible EEG monitoring.
A signiﬁcant barrier to the practice of neuroprotective critical
care in the NICU is the lack of expertise in reporting neonatal
EEG. Current cotside EEG monitors are sophisticated devices, offer-
ing the ability to record multiple channels of EEG continuously
together with other physiological signals and video-recording of
the baby’s movements. They allow the continuous display of
aEEG and other quantitative trends and are easy to set up and
maintain. But few clinicians have the knowledge to interpret the
plethora of information which is generated by such monitoring,
and without this knowledge there is a danger that this equipment
will be under utilised or (worse) the output will be misinterpreted
at the cotside.
Our group has considerable experience with cotside EEG moni-
toring and has grown to appreciate the beneﬁts that this provides.
For many years now we have been working on a seizure detection
algorithm (SDA), which would analyse one or more channels of
‘‘raw’’ EEG, continuously and in real-time, providing a visual and
audible alert to the clinical team. The engineering challenges have
proven formidable because EEG is a complex signal, and neonatal
seizures have variable amplitude, frequency and morphology,
and are rarely sustained for more than 5 min.
Other groups have developed SDAs for neonates, and have pub-
lished their detection rates, using varying deﬁnitions of success
(Liu et al., 1992; Gotman et al., 1997; Smit et al., 2004;
Navakatikyan et al., 2006; Deburchgraeve et al., 2008; Mitra
et al., 2009). Details of the performance of these and other SDAs
are outlined in Table 1 and reviewed further in the discussion.
Currently only two SDAs are commercially available. These are
the Gotman algorithm incorporated into the Stellate EEG system
(Natus Medical Inc, USA); and the ‘Recognize’ algorithm of
Navakatikyan which is incorporated into the Brainz aEEG monitor
(Natus Medical Inc., USA) which has only a 2 channel EEG capabil-
ity. One problem which inhibits comparison of SDAs is the lack of
an agreed deﬁnition of what constitutes best performance. Many
SDAs are reported to have good detection rates, with a high num-
ber of seizures accurately detected when compared to expert neu-
rophysiology as the ‘‘gold standard’’, and low numbers of missed
seizures. However, the temporal aspect of seizure detection is
rarely reported, for example one missed seizure of 8 min duration
in an hour would be clinically important. Another important aspect
of SDA performance assessment is the number of false detections.
Many validation studies have used only short duration recordings,
but any robust algorithm designed for current NICU use has to be
able to perform reliably on very long recordings of 72 h or more.
Respiration artefact is a particular problem often recorded in
neonatal EEG and can mimic the stereotyped rhythmic seizure
activity that is often seen in neonates.
We have previously reported the performance of our neonatal
SDA on a set of 17 seizure babies recorded at Cork University
Maternity Hospital (CUMH), Ireland (Temko et al., 2011a) using a
‘leave one out’ (LOO) cross validation method of analysis, whereby
the data of one patient is used for testing and the others used for
training the algorithm and the process is repeated for each patient
and the mean result reported. A further LOO study was performed
on 38 babies from CUMH (Temko et al., 2013) incorporating an
adaptation to reduce the effects of prolonged artefact and showed
improved performance. This study also incorporated analysis of an
‘unseen’ dataset of 51 babies from CUMH.
The aim of the present study was to validate the performance of
our neonatal SDA on a larger database of unseen, unedited, contin-
uous, multi-channel EEG data from 70 term newborns collected at
2 sites, CUMH and University College London Hospital (UCLH), and
to provide comprehensive measures of SDA performance. While
time based metrics assess the ability of the algorithm to detect
the ‘amount’ of seizure activity (seizure burden) correctly and is,
in a sense, the most precise engineering metric, event based met-
rics provide clinicians with valuable information as to the percent-
age of seizures that will be detected, with important implications
for treatment and also how often the algorithm is likely to alarm
falsely. We therefore report both time based and event based mea-
sures of performance.
2. Methods
2.1. Data acquisition and EEG annotation
Neonates were enrolled from the neonatal intensive care units
of CUMH and UCLH from January 2009 to October 2011 as part
of an on-going study of neonatal seizures. Neonates P37 weeks
gestation were enrolled for EEG monitoring if they fulﬁlled two
or more of the following criteria: Apgar score less than six at ﬁve
minutes; a continued need for resuscitation after birth; any clinical
evidence of encephalopathy, or seizures developed within 72 h of
age.
This study was conducted with approval from the Clinical
Research Ethics Committees of the Cork Teaching hospitals,
Ireland and the National Health Service in the UK, via the
Integrated Research Application Service. Written, informed con-
sent was obtained from at least one parent of each neonate who
participated in this study.
Table 1
Summary of SDAs proposed in the literature. (DB – database, h – hour, S – seizure, NS – non-seizure, Dur – duration, AUC – area under the receiver operator characteristic, Sens –
sensitivity, spec, speciﬁcity, SDR – seizure detection rate, FA/h – false alarms per hour).
Algorithm DB length h (N) S:NS Dur NS neonates AUC Sens (%) Spec (%) SDR (%) FA/h (N/h)
Liu et al. (1992) 1.0 (14) 1:1 Yes 84 98
Gotman et al. (1997) 237 (54) Yes 66 2.3
Smit et al. (2004) 10.4 (19) No 66 90
Navakatikyan et al. (2006) 24 (55) 1:6.8 Yes 83 87 90 2
Lawrence et al. (2009) 2708 (40) Yes 55 0.09
Deburchgraeve et al. (2008) 218 (26) Yes 85 0.66
Cherian et al. (2011) 756 (24) 1:27.9 No 59 66 0.58
Mitra et al. (2009) 120 (76) 1:11.0 Yes 80 0.78
Temko et al. (2011a,b) 268 (17) 1:5.9 No 0.96 90 90 89 1
Temko et al. (2013) 2540 (51) Yes 0.96 71 0.25
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2.1.1. EEG recording
The EEG was recorded using a NicoletOne EEG monitor
(Carefusion, Wisconsin, USA) and the 10:20 EEG electrode place-
ment system adapted for neonates was used with the following
electrodes F4, F3, T4, T3, C4, C3, CZ, O2 and O1. Additional elec-
trodes were positioned at P3 and P4 when possible. Respiration
and ECG was also monitored and signals were stored syn-
chronously with the EEG. The EEG was recorded at a sampling rate
of 250 Hz or 256 Hz, with a ﬁlter bandwidth of 0.5–70 Hz. The EEG
was recorded from as soon as possible after birth and the recording
continued for as long as clinically required.
2.1.2. EEG analysis
All seizures were annotated on the original EEG ﬁle by a trained
electrophysiologist, Sean Mathieson (SM) to generate seizure event
text ﬁles for each recording. The seizure annotations of SM for all
neonates were used for comparison with the SDA annotations. To
verify the validity of the seizure annotations by SM, a random sam-
ple of 15/35 (42.85%) recordings with seizures were also annotated
by Geraldine Boylan (GB) and compared for inter-rater reliability
using Cohen’s Kappa index.
An electrographic seizure was deﬁned as a sudden and evolving
repetitive stereotyped waveform with a deﬁnite start, middle and
end, lasting for at least 10 s on at least one EEG channel (Clancy
and Legido, 1987). A stand alone, ofﬂine version of the SDA was
then used to process each EEG recording (see Fig. 1). Full details
of the alpha version of this algorithm have been described previ-
ously (Temko et al., 2011a). The current beta version incorporates
a modiﬁcation to reduce false detections due to persistent artefact
(Temko et al., 2013). In summary, the EEG is down-sampled to
32 Hz with an anti-aliasing ﬁlter set at 12.8 Hz and is then split
into 8 s epochs with 50% overlap between epochs. Fifty-ﬁve fea-
tures are then extracted for each channel from each epoch repre-
senting both time and frequency domain characteristics as well
as information theory based parameters. Details of main features
extracted are given in Table 2. The features extracted from each
epoch are then fed into a support vector machine classiﬁer. The
output of the SDA is a graph of the probability of seizure calculated
using all features in any one 8 s epoch, from zero to 1. This analysis
is performed separately for each channel then results are combined
for all channels into a single graph (Fig. 1, top panel). A seizure is
designated when the probability graph breaches a threshold. The
seizure sensitivity threshold is adjustable from 0.1 (most sensitive)
to 0.9 (least sensitive). The adjustable threshold allows the algo-
rithm to be tuned on a patient by patient basis. For example,
should an EEG recording contain large amounts of artefact causing
false detections, the SDA can be desensitised to reduce this number
but with a concomitant decrease in the seizure detection rate, as
there will always be a negative trade-off between the number of
detected seizures and false detections. An SDA annotation was
exported for each threshold and was used for comparison with
the expert rater’s annotation. The SDA and the expert rater’s anno-
tations were stored as text ﬁles.
2.2. Assessment of the SDA
Assessment of an SDA against a ‘‘gold standard’’ is not a trivial
task (Temko et al., 2011b). There is a relative scarcity of seizures
in any long duration recording, and in clinical practice recordings
will be made in many babies with no seizures at all. The SDA
may detect a seizure but the assessed duration might not be in
agreement with the ‘‘expert’’ view. The possible output of a com-
parison is demonstrated in Fig. 2, illustrating the true positive sit-
uation (TP) when both the SDA and the expert rater agree there is
seizure activity, and true negative (TN) when neither the rater or
the SDA classify the EEG as showing seizure. A false positive (FP)
Seizure probability output
aEEG F4-C4
aEEG F3-C3
cEEG
Fig. 1. The SDA incorporated into an EEG viewer. The output of the SDA is a graph of the probability of seizure (upper panel). When a seizure is detected the trace turns red
and an annotation is made. The viewer also displays the continuous EEG and aEEG.
Table 2
Main features extracted from the EEG by the SDA.
Groups Feature list
Frequency
domain
 Total power (0–12 Hz)
 Peak frequency of spectrum
 Spectral edge frequency (80%, 90%, 95%)
 Power in 2 Hz width sub-bands (0–2 Hz, 1–3 Hz, ...10–
12 Hz)
 Normalised power in sub-bands
 Wavelet energy (the EEG is decomposed into 8 coefﬁ-
cients using the Daubechy 4 wavelet, the energy in the
5th coefﬁcient corresponding to 1–2 Hz is used as a
feature)
Time domain  Curve length
 Number of maxima and minima
 Root mean squared amplitude
 Hjorth parameters
 Zero crossings (raw epoch, D, DD)
 Autoregressive modelling error (model order 1–9)
 Skewness
 Kurtosis
 Nonlinear energy
 Variance (D, DD)
Information
theory:
 Shannon entropy
 Singular value decomposition entropy
 Fisher information
 Spectral entropy
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or type 1 error occurs when the human expert did not annotate a
seizure but the SDA output is seizure, and a false negative (FN)
or type II error occurs when the expert annotates the recording
as seizure but the SDA does not. In order to achieve a rigorous eval-
uation the probability output time series was set at 60 samples per
minute (1 Hz). In order to measure the agreement between the
annotations of seizure by the SDA and the expert rater, both
records were converted into a binary time series (in this case the
time series sampled at 1 Hz). The binary signal was generated by
denoting the presence of a seizure at any second with ‘1’ and
absence of seizure at any second with ‘0’.
2.2.1. Conventional measures of agreement
Using the concept of true positive and true negative detection
outlined above, conventional measures can be calculated.
Sensitivity, deﬁnes agreement between the human expert and
SDA for identifying the presence of seizure, TP/(TP + FN), and speci-
ﬁcity deﬁnes agreement between the human expert and SDA for
identifying the absence of seizure, TN/(TN + FP). The estimates of
sensitivity and speciﬁcity can be applied directly to the annotation
time series (time based assessment) or in an event based assess-
ment (Fig. 2). The time based metrics correspond to an ‘overlap
integral’ method of assessment (Wilson et al., 2003). The event
based metrics correspond to an ‘any overlap’ method of assess-
ment and must be modiﬁed so that speciﬁcity is replaced by a
measurement of the false detections per hour (false positives per
hour) due to a poorly deﬁned ‘no seizure’ event (Wilson et al.,
2003).The sensitivity and speciﬁcity can also be used to calculated
the area under the receiver operator characteristic (a plot of the
speciﬁcity vs the sensitivity). The effect of seizure duration on
the accuracy of seizure detection (event based analysis) was also
examined.
The assessment of agreement was examined on a case-by-case
basis. Measures of agreement were then summarised across neo-
nates using the median and interquartile range (the distribution
of performance measures will be nonparametric). Agreement was
assessed using Cohen’s Kappa index.
Performance metrics for the current validation study were also
compared against results of the previous ‘leave one out’ study
(Temko et al., 2013).
2.2.2. Application speciﬁc measures of SDA usefulness
The agreement between several interpretations of the annota-
tion was compared using the intra-class correlation coefﬁcient
(ICC). We quantify interpretation as a summary representation of
clinically useful information on seizures over the entire EEG
recording of a baby. This includes summary statistics such as sei-
zure burden, seizure number, mean seizure duration, median sei-
zure duration, seizure onset, and seizure period.
The ability of the SDA to support the identiﬁcation of seizure
and non-seizure babies was also examined, ie. detect any seizures
in seizure babies and make no false detections in non-seizure
babies.
Next the potential of the SDA to support clinical decisions
regarding AED administration was examined. With periodic review
of the EEG, seizures may not be detected immediately and AEDs are
often administered some hours after seizure onset. AEDs may also
be administered based on clinical assessment only, potentially
erroneously. In order to facilitate this analysis, we examined
whether there was seizure activity on the EEG in the 90 min prior
to administration of AED (concurrent with AED), or absent in this
90 min period (non-concurrent with AED) to ascertain whether
AED was given in a timely or appropriate manner. 90 min was
taken as an arbitrary cut off time. This was compared to an exam-
ination of the SDA output to conﬁrm whether AEDs had concurrent
or non-concurrent SDA seizures. This comparison reﬂected the
ability of an SDA to support clinical decisions regarding AED
administration.
3. Results
In total, 107 babies recruited between 5th January 2009 and
30th June 2011 met the inclusion criteria (71 from CUMH and 26
from UCLH). A cohort of 70 babies was then formed by selecting
all 35 who had EEG seizures and 35 babies who did not have
EEG evidence of seizures. The 35 non-seizure babies were ran-
domly selected from the recordings of the remaining 72 babies in
order to match the number of seizure and non-seizure babies in
the cohort. The range of demographics for this cohort of neonates
is given in Table 3.
The seizure annotations by SM resulted in the detection of 2061
seizures in 35 neonates from a total of 4060 h of multi-channel EEG
recordings (Table 4).
3.1. Conventional measures of agreement
Results of the comparison of seizure annotation by SM and GB
produced a mean Kappa score of 0.851, which is considered near
perfect. The level of agreement (time based analysis) between
the annotations of the human expert (SM) and SDA at 9 SDA
thresholds, are shown in Table 5A. The maximal level of agreement
was at sensitivity threshold 0.4. Further time and event based mea-
sures assessed at each SDA threshold are shown in Table 5B.
The results for time based metrics are also shown in Fig. 3.
Fig. 3a compares the performance of the unseen validation study
to the previous ‘leave one out’ cross validation (Temko et al.,
2013). The median AUC for the validation study, estimated on
Fig. 2. Temporal and event based assessment of agreement between the annotation of the human expert and the SDA output. S denotes seizure and NS denotes non-seizure.
Light/shade in time bar denotes periods of temporal agreement/disagreement: true positives (TP), true negatives (TN), false positives (FP) and false negatives (FN). Markers
denote event based agreement: TP and FP. Sensitivity for temporal assessment is 75.0% and speciﬁcity for temporal assessment is 75.0%. Sensitivity for event based
assessment is 66.7% and a false alarm rate of 1/h.
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neonates with seizures (sensitivity can only be estimated on neo-
nates who have seizures) was 0.945 (IQR: 0.921–0.971, min:
0.684 max: 0.999). The mean AUC was 0.933. The performance
curves for the two datasets are similar with slightly improved
results in the validation set. Fig. 3b shows the speciﬁcity for neo-
nates with seizure and neonates without seizure. The curves are
similar with slightly higher speciﬁcity for non-seizure babies than
seizure babies at lower thresholds.
The results for event based metrics on a case by case basis are
shown in Fig. 4. Again the performance curves for the validation
study compared to the LOO cross validation are similar (Fig. 4a).
Fig. 4b shows that false alarm rates are similar for seizure and
non-seizure babies.
Fig. 5 shows seizure detection rates and FDs/h for individual
babies in the cohort. There is variability in seizure detection and
false detection rates across babies. Note the high false detection
rates in seizure babies 25 and 26 due to respiration and pulse
artefact.
Fig. 6 shows the effect of seizure duration on SDA detection rate.
The SDA performance is reduced when detecting short seizures.
The most common seizure duration was 1–2 min.
3.1.1. Application speciﬁc measures of SDA usefulness
The intra-class correlation between estimates of seizure burden,
seizure number, mean/median seizure duration, seizure onset and
seizure period are shown in Table 6 for the highest performing
threshold of the SDA. The highest performing threshold varies
depending on the parameter of interest.
The performance of the SDA to support the identiﬁcation of sei-
zure babies (any seizure detected) and non-seizure babies (no false
detections) at several clinically relevant thresholds is shown in
Fig. 7. There is a trade-off between number of seizure and
non-seizure babies detected depending on the SDA sensitivity
threshold. The best performing SDA sensitivity threshold was at
0.8 (30/35 seizure babies identiﬁed, 31/35 non-seizure babies
identiﬁed). Clinical recognition of seizure/non-seizure babies
(identiﬁcation of a seizure baby was assumed if AED was given,
identiﬁcation of a non-seizure baby was assumed if AED not given)
was slightly superior to the SDA (33/35 seizure babies identiﬁed,
30/35 non-seizure babies identiﬁed). The SDA did not detect any
seizures that had been missed by the expert reviewer in the
non-seizure baby group.
The potential of the SDA to support clinical decisions regarding
AED administration is shown in Fig. 8. A total of 97 AED adminis-
trations were recorded (NB. Maintenance doses were not anal-
ysed). Of these, 78 were administered during EEG recording.
53/78 were concurrent with EEG seizures (within 90 min preced-
ing AED administration) and 25/78 were administered with no
concurrent seizures (in the 90 min preceding AED administration).
Again there is a trade-off in the performance of the SDA to support
clinical decisions regarding AED administration between support-
ing concurrent and non-concurrent AED decisions, dependent on
SDA sensitivity threshold. The data does suggest however that
Table 3
Demographics and EEG recording information relating to the 70 neonates used in this
study.
Gestational age (weeks+days) 40+3 (39+2 to 41+2)
Birthweight (g) 3526 (3140 to 3920)
Gender (male:female) 37:33
Age at EEG onset (h) 7.0 (3.6–19.0)
EEG recording duration (h) 51.6 (21.5–84.4)
Primary diagnoses Neonates (N)
HIEa 37
Mild 10
Moderate 19
Severe 8
Birth depressionb 10
Strokec 8
Focal lesiond 3
Othere 12
 Median (interquartile range).
a 22 treated with therapeutic hypothermia (TH).
b Birth depression without ensuing encephalopathy.
c Stroke – arterial ischaemic, haemorrhagic, multiple infarctions.
d Focal lesion – subdural haemorrhage, intraparenchymal bleed.
e Other – meningitis/HIE (TH), viral encephalitis, sepsis, benign familial neonatal
seizures, benign sleep myoclonus, unknown diagnosis.
Table 4
The summary of seizure characteristics in the 35 babies with EEG conﬁrmation of
seizures. Seizure onset (h) refers to post natal age in hours.
Median IQR min max
Seizure onset (h) 19.0 (11.5–35.8) 6.6 153.8
Seizure period (h) 18.6 (8.6–35.4) 0.03 120.2
Seizure burden (mins) 79.8 (25.3–204.6) 1.9 1404
Seizure number (N) 22 (7–75) 1 295
Mean seizure duration (s) 163 (95–298) 28 2207
Median seizure duration (s) 115 (69–186) 25 2207
Table 5
The level of agreement between the annotation of the human expert (SM) and the
SDA at 9 thresholds. (A) Cohen’s Kappa Index (time based metric), (B) sensitivity and
speciﬁcity (time based metric), seizure detection rate and false alarms per hour (event
based metrics). Data are median (IQR).
SDA
threshold
Kappaa Prevalence indexa Bias indexa
(A)
0.1 0.098
(0.044–0.204)
0.688
(0.588–0.780)
0.222
(0.157–0.364)
0.2 0.309
(0.155–0.509)
0.893
(0.785–0.949)
0.050
(0.027–0.098)
0.3 0.524
(0.217–0.677)
0.936
(0.862–0.977)
0.011
(0.003–0.031)
0.4 0.630
(0.283–0.739)
0.956
(0.885–0.984)
0.006
(0.003–0.019)
0.5 0.579
(0.332–0.724)
0.954
(0.896–0.983)
0.007
(0.002–0.019)
0.6 0.552
(0.340–0.700)
0.952
(0.864–0.981)
0.006
(0.003–0.019)
0.7 0.405
(0.255–0.621)
0.959
(0.879–0.983)
0.001
(0.003–0.027)
0.8 0.280
(0.135–0.406)
0.957
(0.889–0.989)
0.011
(0.004–0.038)
0.9 0.060
(0–0.207)
0.941
(0–0.981)
0.007
(0–0.042)
SDA
threshold
Sensitivitya Speciﬁcityb Seizure
detection ratea
False alarm
rateb
(B)
0.1 96.2
(92.6–98.4)
77.7
(63.0–86.6)
97.1
(92.2–100.0)
4.35
(3.28–5.70)
0.2 88.1
(80.5–92.3)
94.5
(91.1–97.9)
85.7
(77.1–97.6)
1.20
(0.63–2.01)
0.3 76.1
(68.5–83.9)
98.5
(97.0–99.5)
75.0
(59.5–91.7)
0.36
(0.16–0.74)
0.4 68.6
(56.3–80.2)
99.5
(98.6–99.9)
64.0
(41.6–85.3)
0.12
(0.04–0.29)
0.5 58.6
(41.2–70.4)
99.8
(99.3–100.0)
52.6
(28.3–73.4)
0.04
(0–0.18)
0.6 44.2
(31.4–70.0)
99.9
(99.7–100.0)
50.0
(23.1–60.1)
0
(0–0.06)
0.7 32.1
(15.0–51.0)
100.0
(99.9.0–100.0)
34.2
(13.4–50.0)
0
(0–0.01)
0.8 16.4
(7.4–30.9)
100.0
(100.0–100.0)
23.7
(7.2–38.9)
0
(0–0)
0.9 3.4
(0–12.1)
100.0
(100.0–100.0)
5.1
(0–16.2)
0
(0–0)
a Estimated on neonates with seizure (N = 35).
b Estimated on all neonates (N = 70).
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there is a potential for the SDA to beneﬁcially support these
decisions. The SDA, at a threshold of 0.5 and 0.6 performed equally
well in terms of its overall effectiveness to correctly identify
seizures or seizure free EEG in the 90 min preceding AEDs and
therefore to potentially support clinical decisions regarding AED
administrations. At a threshold of 0.5, 45/53 (85%) AED administra-
tions concurrent with EEG evidence of seizure would be supported
by the SDA and only 6/25 (24%) of AED administrations with
non-concurrent seizures would be supported by the SDA., ie. the
SDA has the potential to reduce non-concurrent AED administra-
tion by 76% at a cost of not detecting 15% of concurrent seizures.
3.2. Missed seizures and false detections
Examples of seizures that were not detected by the SDA are
illustrated in Fig. 9. These were often short or low amplitude or
had a dysrhythmic or complex morphology. A quantitative analysis
of both missed seizures and false detections will be published sep-
arately. Some common causes of false detection are shown in
Fig. 10. Respiration and pulse artefacts are recognisable as they
are synchronized to the respiration and ECG traces respectively.
Sweat artefact produces characteristic large semi-rhythmic waves
spanning several seconds. A highly rhythmic background EEG pat-
tern also caused false detections in some cases. This pattern was
often observed in intermediate sleep, a phase between active and
passive sleep, when widespread delta activity is known to increase.
In some cases this delta activity had an increased rhythmicity than
is commonly observed and consequently caused false detections.
This is evident in Fig. 10d where the periodic peaks in the CFM
indicating intermediate/quiet sleep correspond to peaks in the
SDA probability output and a highly rhythmic EEG pattern is
shown in the lower panel.
4. Discussion
In this study a comprehensive set of metrics have been used to
measure the performance of our SDA on a large, unedited dataset
of prolonged, clinical EEGs from two institutions. To the best of
our knowledge this is the largest data set used for SDA validation
in babies to date. Only a small subset of previous SDAs has been
investigated on a large cohort of babies (Gotman et al., 1997;
Lawrence et al., 2009; Mitra et al., 2009; Cherian et al., 2011).
We have used a reduced set of 9 recording electrodes in our
study which the algorithm is preset to analyse. While some centres
may favour a full set of electrodes (up to 32 recording electrodes)
Fig. 3. Time based measures (overlap integral) of SDA performance. The broken
lines denote the interquartile range. (A) The median receiver operator curves (the
trade-off between sensitivity and speciﬁcity) of validation set (estimated on babies
with seizure, N = 35) compared to ‘leave one out’ cross validation set (Temko et al.,
2013). The numbers on the plot relate to the threshold at which the sensitivity and
speciﬁcity were estimated. (B) The median speciﬁcity of the SDA for validation set
with respect to SDA threshold, estimated on babies with seizure (N = 35) and babies
without seizure (N = 35) in validation study.
Fig. 4. Event based measures (any overlap) of SDA performance compared to the
original LOO cross-validation. The broken lines denote the interquartile range. (A)
The trade-off between seizure detection rate and false alarms per hour for babies
with seizure (N = 35) in validation study compared to ‘leave one out’ cross
validation study (Temko et al., 2013). The numbers on the plot relate to the
threshold at which the sensitivity and speciﬁcity were estimated. (B) The median
false alarm rate with respect to SDA threshold estimated on babies with seizure
(N = 35) and babies without seizure (N = 35) in validation study.
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which are useful for the purposes of seizure onset localisation, our
primary goal is seizure detection. A study by Tekgul et al. (2005)
comparing seizure detection between a full 10:20 montage and a
reduced 9 electrode set, found very few seizures were missed with
a sensitivity of 96.8% for the reduced montage compared to the full
set. The beneﬁts of using more electrodes must be weighed against
the time and technical constraints to the NNU staff of applying
more electrodes out of hours.
We have found the performance of our algorithm to compare
favourably with those previously reported by others (Table 1),
although in previous papers not all metrics were reported for full
comparison. For example Gotman (Gotman et al., 1997) reported
a SDR of 66% with a FD rate of 2.3 FD/h. At a threshold of 0.3, the
SDA reported here achieved a higher SDR of 75% at a much lower
FD rate of 0.4 FD/h.
Navakatikyan (Navakatikyan et al., 2006), reported a SDR of 90%
at 2 FD/h. In comparison, at a threshold of 0.2 our system achieved
a slightly lower SDR rate of 85%, but with a much lower false detec-
tion rate of 1.2FD/h. In a clinical validation study of the
Navakatikyan algorithm, Lawrence (Lawrence et al., 2009) com-
pared the output of the algorithm with 12 h recordings of conven-
tional video-EEG, and found a seizure detection rate of 55% with a
false detection rate of 0.1 FD/h. This was quite different to the ini-
tial performance results (Navakatikyan et al., 2006). At a threshold
of 0.5, the system reported here achieved a slightly lower SDR of
53% but again with a lower FD rate of 0.04/h.
Deburchgraeve et al. (2008) initially reported an SDR of 85%
with a FD rate of 0.7FD/h. At a threshold of 0.2, our system
achieved a similar SDR of 86% with a higher FD rate of 1.2 FD/h.
However in a clinical validation of this algorithm, Cherian et al.
(2011) reported a lower SDR rate of 66% with a FD rate of
0.58 FD/h. At threshold 0.4 our system achieved only a slightly
lower SDR rate of 64.0% but with a considerably lower FD rate of
0.12 FD/h.
Fig. 5. Seizure detection rates and FDs/h (SDA sensitivity threshold 0.5) for individual babies in the cohort. Note the high false detection rates in seizure babies 25 and 26 due
to respiration and pulse artefact. Babies to the left of the vertical line were babies recruited in Cork and those to the right were recruited in London.
Fig. 6. Analysis of seizure detection rate with respect to seizure duration. (A) SDA
performance with respect to seizure duration over nine thresholds. (B) The
distribution of seizure durations throughout the concatenated recording.
Table 6
Agreement between interpretation of annotations of the human expert (SM) and the
SDA. Interpretation relates to summary statistics of the temporal evolution of seizures
in each EEG recording. The average intra-class correlation coefﬁcient (ICC) is
presented and is estimated on the entire cohort of babies (N = 70). The summary
statistics of seizures are estimated from the SDA annotation but only on babies who
have seizure as detected by the human expert. The threshold that results in the
highest ICC for each measure is shown. The SDA detects at least one seizure in 64, 54,
43, 38 babies at thresholds of 0.4, 0.5, 0.6, 0.7 respectively.
Median IQR ICC SDA
threshold
Seizure onset (h) 15.1 (7.7–32.5) 0.722 0.4
Seizure period (h) 26.3 (7.3–49.8) 0.802 0.6
Seizure burden (mins) 81.1 (26.6–181.3) 0.859 0.5
Seizure number (N) 35 (7–72) 0.930 0.4
Mean seizure duration (s) 169 (121–243) 0.511 0.5
Median seizure duration (s) 124 (92–146) 0.323 0.7
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The SDA presented by Mitra et al. (2009) gave a SDR of 80% with
a FD rate of 0.78 FD/h. The SDR is midway between the SDR rates
reported here at threshold 0.3 (75.0%) and 0.2 (85%) with FD rates
at 0.36 FD/h and 1.20 FD/h respectively, thus at 80% detection rate
our FD rate would be comparable to that of Mitra.
In this study, the performance of our SDA on an unseen dataset
mimicked the performance seen in the previous ‘leave one out’
cross validation (Temko et al., 2013). In ‘leave one out’ cross valida-
tion the data for each patient is tested using the data for all other
patients as training data for the algorithm and the process repeated
for each patient and the results averaged. These results suggest
ﬁrstly that the data set used to train the algorithm contained a rep-
resentative population of seizure and background EEG patterns and
secondly that the SDA performs equally well on unseen data, as
will be encountered in clinical use.
This study, in conjunction with the paper by Temko et al.
(2013), are also the ﬁrst papers to evaluate the SDA in a so-called
‘mismatch’ situation, where the seizure annotations of one expert
are used to train the algorithm and the annotations of another
expert are used to test the SDA. In addition, in this paper, we have,
for the ﬁrst time, tested the algorithm on data collected from two
different centres, CUMH and UCLH, with potential differences in
EEG application and recording. Given these two factors, the simi-
larity of current SDA performance with previous performance
demonstrates a practically acceptable degree of robustness of the
algorithm.
The current performance, analysed with a very rigorous deﬁni-
tion of true positive and true negative detections, was very good
for most babies with seizures (Fig. 5). Two seizure babies (25 and
26) had high false detection rates due to respiration and pulsatile
artefact. In future, it may be possible to teach clinical staff simple
artefact ‘‘pattern’’ recognition (Fig. 10) so that false detection
would not lead to overtreatment. For example, respiration and pul-
satile artefact are both easily recognised as they are synchronized
to the respiration and ECG traces respectively and are invariant as
they do not show the evolving features of many seizures. Similarly
sweat artefact produces characteristic high amplitude,
semi-rhythmic slow waves spanning several seconds, a far slower
frequency than typical seizures. Indeed, the results of the pilot
study by Lawrence et al. in which pre-training was given, support
this with only 1 single dose of AED given inappropriately in 232
false detection events (Lawrence et al., 2009).
The analysis of AED administration has shown that on 25 occa-
sions AEDs were given without EEG seizures in the preceding
90 min and that the SDA has the potential to support clinical deci-
sions to reduce AED administrations with ‘non-concurrent’ sei-
zures. We are not suggesting that in 25 cases AEDs were given
‘inaccurately’ by clinical staff, In only one case did we identify that
an AED had been given on clinical suspicion of seizure alone (with-
out any EEG correlate at all). In most cases we suspect that there
was simply a delay in detection of seizure and AED administration
due to the nature of periodic EEG review which could potentially
have been reduced with the support of the algorithm alerting clin-
ical staff earlier.
The performance of the SDA has been presented over a range of
sensitivity thresholds and the metrics used allow ‘best performing’
thresholds to be determined. However the choice of sensitivity
threshold used in a clinical environment is critically dependent
on the fact that best performing thresholds differ with tasks and
threshold choice is therefore dependent on the requirement of
the user. For example, the best performing threshold for detecting
the maximal number of seizure/non-seizure babies correctly
(Fig. 7) was threshold 0.8 while for supporting decisions regarding
AED administration (Fig. 8), thresholds of 0.5/0.6 were optimal. The
intra-class correlations in Table 6 show a variety of best perform-
ing thresholds for different parameters of interest. Notably, for
detecting seizure onset and seizure number, a threshold of 0.4 per-
formed best. For the task of correctly detecting the greatest
‘amount’ of seizure/non-seizure activity (seizure burden), time
based analysis provides the most accurate measure and the
Kappa score comparing human and SDA annotations indicated that
the best performing threshold was also 0.4 (Kappa 0.630).
In clinical practice however, it is not likely that clinicians will be
concerned with accurately detecting every single second of each
seizure and are likely to care most that the SDA makes ‘some’
detection during a seizure and that overall the output of the SDA
most accurately represents the numbers of seizures occurring with
an acceptable false detection rate. This would allow treatment to
be titrated to the presence of ongoing seizures, and in this respect
the event based metrics may be of more interest clinically. The
concept of what is deemed acceptable in terms of the rate of false
Fig. 7. The accuracy of the SDA for the identiﬁcation of seizure and non-seizure
babies at several thresholds. There were 35 neonates with EEG evidence of seizure
and 35 neonates without EEG evidence of seizure. Clinical recognition is based on
AED administration and is superior to the SDA.
Fig. 8. Potential of the SDA to support decisions on AED administration. A total of
97 AED administrations were recorded. Of these, 78 were administered concur-
rently with EEG recording and 53 were concurrent with EEG seizures (seizures
occurring in the 90 min prior to AED adminstration). At a threshold of 0.5, 45 (85%)
AED administrations concurrent with EEG evidence of seizure and only 6 (24%) of
AED administrations with no EEG evidence of seizure would be supported by the
SDA.
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alarms is also dependent on user preference and may vary between
users, affecting the choice of sensitivity threshold.
We consider the output from the SDA at thresholds from 0.5 to
0.3 to be within a clinically acceptable range, giving detection rates
between 52.6% and 75.0% with false detections, on
average, approximately every 20 and 3 h respectively (Table 5B).
This range is proposed on the basis of a perceived expectation that
a minimum of 50% seizure detection is required and that a
false detection rate of greater than 0.5/h might be considered
excessive.
The data presented here represents only one stage in the assess-
ment of the SDAs performance which will be further tested in a
 
Short seizures 
(A)
 
(B)
Fig. 9. Seizures missed by the SDA. (A) Brief 30 s seizure. 0 of 4 seizures were detected in this record (thr 0.5), though the algorithm output would cause the clinician to
interrogate the EEG at various points despite the fact that the ﬁxed threshold was not reached. (B) Subtle, dysrhythmic 2 min seizure with complex morphology, 0 of 1
seizures were detected in this record (thr 0.5). (C) Low amplitude seizure, 31 of 55 seizures were detected in this record (note. Non detected seizures produce clear peaks on
the probability trace for interrogation).
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‘live’ multicentre randomised clinical evaluation (the ANSeR study
– Algorithm for Neonatal Seizure Recognition http://clinicaltri-
als.gov/show/NCT02160171). For this study the threshold will be
preset at 0.5 for purposes of equivalence across participating
centres.
It is important to state that the SDA is not intended to replace
clinician’s review of the EEG or to be viewed as a ‘decision maker’
with regard to the presence, or not, of seizures. Its purpose is only
to highlight areas of interest for further review. In this respect, a
crucial aspect of the algorithm’s output is the graph of the
Undetected 
seizures
Detected 
seizures
(C)
Fig. 9 (continued)
 
 
False detecons due 
to persistent 
respiraon artefact 
Respiraon artefact on 
EEG synchronized with 
respiraon trace 
(A)
Fig. 10. Causes of false detection. (A) Respiration artefact. Upper panel shows output from SDA, lower panel shows rhythmic respiration artefact on EEG synchronized with
respiration trace (from motion sensor). (B) Pulse artefact synchronized to ECG trace. (C) Sweat artefact with characteristic high amplitude semi-rhythmic slow waves
spanning several seconds. (D) Highly rhythmic background EEG occurring in the intermediate sleep phase. Note how periodic episodes of intermediate/quiet sleep indicated
by the CFM are coincident with periods of raised seizure probability output on the SDA graph and a highly rhythmic EEG in the lower panel.
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Pulse artefact 
synchronized 
with ECG trace 
False detecons 
due to persistent 
pulse artefact 
Seizures 
(B)
Fig. 10 (continued)
(C)
Fig. 10 (continued)
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probability of seizure. A clinician reviewing the output of the SDA
at the cotside is likely to interrogate both prominent peaks that
breach the threshold on the graph and others that do not (eg.
Fig. 9c). With a ‘‘pattern recognition’’ support package, the ability
of clinicians to differentiate seizures from artefacts can, potentially,
be improved. For these reasons, the role of the reviewer is central
to the interpretation of the output of the SDA and consequently
how many seizures, false detections, seizure babies and
non-seizure babies are identiﬁed correctly. Our intention is that
the seizure detection performance of clinicians with the assistance
of our algorithm will be superior to the algorithm’s simple binary
‘alerts’ based on ﬁxed thresholds presented here.
5. Conclusion
We have validated a neonatal SDA on a large EEG dataset and
have shown that it achieves a clinically useful level of seizure
detection with acceptable false detection rates. Future
multi-centre evaluation of the SDA in a ‘live’ clinical environment
will critically investigate the clinician’s interpretation of the full
SDA output to determine the usefulness of the SDA in the NICU.
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